181.99
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating - MSN
Is a relief rally coming for Praxis Precision Medicines Inc. holdersQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com
How analysts rate Praxis Precision Medicines Inc. stock today2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com
What institutional flow reveals about Praxis Precision Medicines Inc.2025 Fundamental Recap & Weekly High Momentum Picks - newser.com
Is Praxis Precision Medicines Inc. stock near bottom after decline2025 Buyback Activity & AI Enhanced Trading Alerts - newser.com
How institutional buying supports Praxis Precision Medicines Inc. stockJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com
Is Praxis Precision Medicines Inc. stock a contrarian buyJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Can Praxis Precision Medicines Inc. stock deliver surprise earnings beatWeekly Risk Summary & High Yield Equity Trading Tips - newser.com
Applying big data sentiment scoring on Praxis Precision Medicines Inc.Bull Run & Reliable Volume Spike Trade Alerts - newser.com
Using Python tools to backtest Praxis Precision Medicines Inc. strategiesWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-03 03:06:20 - newser.com
Does Praxis Precision Medicines Inc. qualify in momentum factor screeningWall Street Watch & Weekly Top Gainers Trade List - newser.com
Published on: 2025-11-02 22:52:57 - newser.com
How Praxis Precision Medicines Inc. stock valuations compare to rivalsTrade Analysis Summary & Long-Term Capital Growth Strategies - newser.com
Praxis Precision Medicines prices $525M public offering - MSN
Published on: 2025-11-01 00:59:14 - newser.com
Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Praxis Precision Medicines stock hits 52-week high at $206.36 By Investing.com - Investing.com Australia
Published on: 2025-10-31 03:19:21 - newser.com
What valuation multiples suggest for Praxis Precision Medicines Inc. stockDividend Hike & Proven Capital Preservation Tips - newser.com
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Praxis Precision Medicines stock hits 52-week high at $206.36 - Investing.com
Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Published on: 2025-10-29 21:58:45 - newser.com
What’s Happening With Praxis Stock? - Trefis
Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - Sahm
Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy? - sharewise.com
Published on: 2025-10-29 03:41:05 - newser.com
Praxis Precision Medicines’ PRAX-562 Trial: A Potential Game-Changer for Epileptic Encephalopathies - TipRanks
Praxis Precision Medicines (PRAX) Price Target Increased by 153.57% to 258.64 - Nasdaq
Praxis Precision Medicines Signs New Sales Agreement - MSN
Praxis Precision Medicines, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):